NCT03312595View on ClinicalTrials.gov

Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU)

NACompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 14, 2017

Primary Completion Date

July 15, 2018

Study Completion Date

July 30, 2018

Conditions
Diabetic Foot Ulcer
Interventions
DEVICE

Restrata TM Wound Matrix

The RestrataTM Wound Matrix is a sterile, single use device intended for use in local management of wounds

Trial Locations (5)

75208

Richard C. Galperin, DPM, Dallas

85015

Associated Foot & Ankle Specialists, Phoenix

85710

Arizona Reginal Medical Research, Tucson

85723

SAVAHCS, Tucson

93722

Advanced Foot Care And Clinical Research Center, Fresno

Sponsors
All Listed Sponsors
lead

Acera Surgical, Inc.

INDUSTRY

NCT03312595 - Clinical Outcomes After Treatment With RestrataTM Wound Matrix in Diabetic Foot Ulcers (DFU) | Biotech Hunter | Biotech Hunter